WuXi Biologics (Cayman) Inc ( WXXWY) reported a 7.7% growth in non-COVID revenue for the first half of 2024, indicating solid ...

With confidence dropping in doing business with China-affiliated life sciences companies due to the Biosecure Act, one of the companies explicitly named in the U.S. legislation is fighting back.

Korean biopharmaceutical companies are exploring opportunities at Bio Japan 2024 amid U.S.-China tensions, with major firms ...

China's WuXi AppTec will raise $500 million in a convertible bond sale, according to a regulatory filing on Tuesday, a month ...